Motivation and Objectives

In 2017, the World Health Organization (WHO) included snakebite envenoming in its list of neglected tropical diseases (NTDs), and in 2018, the World Health Assembly (WHA) adopted a resolution calling on Member States to (i) to assess the burden of snakebites, (ii) promote community awareness of snakebite envenoming to support early treatment and prevention, (iii) to provide training to relevant health workers on diagnosis and management of snakebite envenoming, (iv) improve the availability, accessibility and affordability of antivenoms to the population at risk, and (v) intensify and support research on snakebite envenoming. In 2019, the WHA launched a strategy for prevention and control of snakebite envenoming. The core of the strategy is the goal for all patients to have better overall care so that the burden of mortality and disability is reduced by 50% in 2030.                                                                                                          

Our main aim is to contribute to the WHO's strategy to reduce morbidity and mortality of snakebite envenoming. To do so, we are conducting studies with local partners on:

1) epidemiology of snakebites and venomous snakes in different geographical regions of the target countries,

2) availability of appropriate and effective antivenoms, and

3) clinical aspects of snakebite envenoming

Furthermore, we provide training for healthcare workers in management of snakebites, and develop guidelines that are adapted to the respective national circumstances.

If you want to know more about our projects and cooperation partners, please visit our page Research Projects.




The picture shows a photograph of a green mamba close up on a tree branch. The head of the snake can be seen from the side. Its right eye and the scales of its head are clearly visible. The rest of the body fades towards the upper left edge of the picture.
Grüne Mamba (Dendroaspis angusticeps)
©Friederike Hunstig
Zu sehen ist ein Forscher vor einer Backsteinmauer. Er zeigt einen sehr freundlichen Gesichtsausdruck.
Research Group Leader

Dr. Benno Kreuels

Telefon: +49 40 285380-723